产品
  • 产品
搜索

JML PHARMTECH CO., LTD

CUSTOMER SUPPORT

Jimmylee@jmlpharm.com

CONTACT US

+(86) 595-88013521

HOME >> PRODUCTS >>API >> Dapagliflozin 461432-26-8
详细说明

Dapagliflozin 461432-26-8

98.5% up, EP/USP/BP
99% up by HPLC, GMP application / PMDA / DMF
收藏
  • Product Details

Product Information                                                                


Product name

Dapagliflozin

CAS No.

461432-26-8

Molecular Formula

C21H25ClO6

Molecular Weight

408.879

Quality Standard

98% up by HPLC

Appearance

White to pale yellow powder


COA of Dapagliflozin


ITEMS

SPECIFICATION

RESULT

Appearance

White to pale yellow powder

Conforms



Related substance

Purity(HPLC)  99.0%

99.8%

Single impurity  0.5%

0.08% max

Total impurity  1.0%

0.2%

Water

 3.0%

1.5%

Conclusion

The sample meets the standard requirements


Usage


Dapagliflozin is a new type of antidiabetic drug, a sodium-glucose cotransporter 2 inhibitor, and the first SGLT2 inhibitor approved for the treatment of type 2 diabetes. Important choice for improving glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes.


 CONTACT US

         QUANZHOU JML PHARMTECH CO., LTD


PHONE

+86-595-88013521

+86 15860782800

LOCATION

NO.999 Quanan Rd. (M), Qingyang Street, Jinjiang, Quanzhou, Fujian 362200, China

EMAIL
Jimmylee@jmlpharm.com

技术支持: 泉州世纪通锐信息技术有限公司 | 管理登录
×
seo seo